Please select the option that best describes you:
Topics:
General Internal Medicine • Gastroenterology • Obesity Medicine • Primary Care • General Primary Care
How do you decide which GLP-1s to prescribe for obesity?
Are there any potency or effectiveness preferences that lead to that decision?
Answer from: at Community Practice
Unfortunately, it is the insurance companies who are making the decisions about which GLP-1 I can use, if at all. If insurance is not an issue, I will usually choose Zepbound over Wegovy due to its better efficacy (21% loss in studies vs 15%) and better tolerability. However, if patients are paying ...
Sign In or Register to read more